OnabotulinumtoxinA for Prevention of Migraine in Adults - Cochrane for Clinicians - ...
Feb 1, 2020 - OnabotulinumtoxinA reduces the number of migraine days per month by two days compared with placebo in adults with chronic migraines.
American Family Physician : Cochrane for Clinicians
https://www.aafp.org/afp/2020/0201/p144.html
navigate_before 1 navigate_next